1 ANNEX, Regulation (EU) 2017/841

In forcesince 18 May 2017

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

In the sixth column, expiration of approval, of row 11 Bentazone, the date is replaced by ‘30 June 2018’;

(2)

In the sixth column, expiration of approval, of row 15 Diquat, the date is replaced by ‘30 June 2018’;

(3)

In the sixth column, expiration of approval, of row 19 DPX KE 459 (flupyrsulfuron-methyl), the date is replaced by ‘30 June 2018’;

(4)

In the sixth column, expiration of approval, of row 23 Pymetrozine, the date is replaced by ‘30 June 2018’;

(5)

In the sixth column, expiration of approval, of row 35 Famoxadone, the date is replaced by ‘30 June 2018’;

(6)

In the sixth column, expiration of approval, of row 37 Metalaxyl-M, the date is replaced by ‘30 June 2018’;

(7)

In the sixth column, expiration of approval, of row 39 Flumioxazine, the date is replaced by ‘30 June 2018’;

(8)

In the sixth column, expiration of approval, of row 41 Imazamox, the date is replaced by ‘31 July 2018’;

(9)

In the sixth column, expiration of approval, of row 42 Oxasulfuron, the date is replaced by ‘31 July 2018’;

(10)

In the sixth column, expiration of approval, of row 44 Foramsulfuron, the date is replaced by ‘31 July 2018’;

(11)

In the sixth column, expiration of approval, of row 46 Cyazofamid, the date is replaced by ‘31 July 2018’;

(12)

In the sixth column, expiration of approval, of row 53 Pendimethalin, the date is replaced by ‘31 July 2018’;

(13)

In the sixth column, expiration of approval, of row 59 Trifloxystrobin, the date is replaced by ‘31 July 2018’;

(14)

In the sixth column, expiration of approval, of row 60 Carfentrazone ethyl, the date is replaced by ‘31 July 2018’;

(15)

In the sixth column, expiration of approval, of row 62 Fenamidone, the date is replaced by ‘31 July 2018’;

(16)

In the sixth column, expiration of approval, of row 63 Isoxaflutole, the date is replaced by ‘31 July 2018’;

(17)

In the sixth column, expiration of approval, of row 78 Chlorpropham, the date is replaced by ‘31 July 2018’;

(18)

In the sixth column, expiration of approval, of row 83 Alpha-cypermethrin, the date is replaced by ‘31 July 2018’;

(19)

In the sixth column, expiration of approval, of row 84 Benalaxyl, the date is replaced by ‘31 July 2018’;

(20)

In the sixth column, expiration of approval, of row 85 Bromoxynil, the date is replaced by ‘31 July 2018’;

(21)

In the sixth column, expiration of approval, of row 86 Desmedipham, the date is replaced by ‘31 July 2018’;

(22)

In the sixth column, expiration of approval, of row 88 Phenmedipham, the date is replaced by ‘31 July 2018’;

(23)

In the sixth column, expiration of approval, of row 93 Ampelomyces quisqualis Strain: AQ 10, the date is replaced by ‘31 July 2018’;

(24)

In the sixth column, expiration of approval, of row 95 Laminarin, the date is replaced by ‘31 July 2018’;

(25)

In the sixth column, expiration of approval, of row 96 Methoxyfenozide, the date is replaced by ‘31 July 2018’;

(26)

In the sixth column, expiration of approval, of row 97 S-metolachlor, the date is replaced by ‘31 July 2018’;

(27)

In the sixth column, expiration of approval, of row 98 Gliocladium catenulatum Strain: J1446, the date is replaced by ‘31 July 2018’;

(28)

In the sixth column, expiration of approval, of row 99 Etoxazole, the date is replaced by ‘31 July 2018’;

(29)

In the sixth column, expiration of approval, of row 109 Bifenazate, the date is replaced by ‘31 July 2018’;

(30)

In the sixth column, expiration of approval, of row 110 Milbemectin, the date is replaced by ‘31 July 2018’.